Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Consistent reduction in the annualized rate of brain volume loss across phase 3 core and extension trials of fingolimod in relapsing multiple sclerosis.
Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
Chronic over-expression of TGFβ1 alters hippocampal structure and causes learning deficits.
Objectification of psychogenic postural instability by trunk sway analysis.
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.
Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial.
Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.
The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
Cell type- and brain region-resolved mouse brain proteome.
Systematic review of correlates and determinants of physical activity in persons with multiple sclerosis.
Astrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis.
Myopathy associated with Neuromyelitis Optica Spectrum Disorders.
Therapeutic Potential of the Modulation of Sphingosine 1 phosphate receptors.
Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair.
Paced auditory serial addition test: National normative data.
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.
Role of oral teriflunomide in the management of multiple sclerosis.
Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS.
Nonapoptotic and Extracellular Activity of Granzyme B Mediates Resistance to Regulatory T Cell (Treg) Suppression by HLA-DR-CD25hiCD127lo Tregs in Multiple Sclerosis and in Response to IL-6.
Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes.
Neuronal expression of the transcription factor serum response factor modulates myelination in a mouse multiple sclerosis model.
Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?

Pages